The Board of GlaxoSmithkline Consumer Healthcare at its meeting held on 01 April 2020 has taken on record the sanction of the Scheme of merger by way of absorption of the company into Hindustan Unilever by Hon'ble NCL T Mumbai Bench and Chandigarh Bench.

Wednesday, 01 April 2020, has been fixed as the Effective Date of the Scheme and on which date the certified copy of the Hon'ble NCLT, Chandigarh Bench's order will be filed with the Registrar of Companies.

The Appointed Date of the Scheme is 01 April 2020 i.e., the Effective Date, as set out in the Scheme and approved by the' Hon'ble NCLT, Mumbai Bench and Chandigarh Bench. All the assets and liabilities ofTransferor Company shall become assets and liabilities of the Transferee Company with effect from the Appointed Date.

The Board has approved the record date of 17 April 2020 for allotment of 4.39 equity shares of Hindustan Unilever for each share of the company.

Powered by Capital Market - Live News

GlaxoSmithkline Consumer Healthcare will hold a meeting of the Board of Directors of the Company on 1 April 2020.

Powered by Capital Market - Live News

Net profit of GlaxoSmithkline Consumer Healthcare rose 25.14% to Rs 276.63 crore in the quarter ended December 2019 as against Rs 221.06 crore during the previous quarter ended December 2018. Sales rose 3.76% to Rs 1158.86 crore in the quarter ended December 2019 as against Rs 1116.82 crore during the previous quarter ended December 2018.

Powered by Capital Market - Live News

GlaxoSmithkline Consumer Healthcare will hold a meeting of the Board of Directors of the Company on 6 February 2020.

Powered by Capital Market - Live News